According to Science Magazine, The Feinstein Institutes for Medical Research, released a statement Friday citing evidence it was helpful for COVID-19. However, the statement also said, “We have yet to prove [famotidine’s] efficacy.” The institute says it’s “eagerly awaiting” FDA approval of a trial that will evaluate whether famotidine can help people who are not hospitalized.